How is Multiple myeloma diagnosed?

Multiple myeloma is diagnosed through a combination of blood and urine tests, bone marrow biopsies, and specialized imaging to detect malignant plasma cells and organ damage. A definitive diagnosis typically follows the International Myeloma Working Group (IMWG) criteria, which requires at least 10% clonal bone marrow plasma cells plus evidence of end-organ damage or specific biomarkers.

How is Multiple myeloma diagnosed?

The diagnostic process for Multiple myeloma often begins when routine blood work reveals elevated protein levels or unexplained anemia. Because symptoms can be vague—such as bone pain or fatigue—patients often experience a "diagnostic odyssey," visiting multiple specialists before reaching a hematologist-oncologist. At DiseaseMaps.org, 217 community members have navigated these challenges, highlighting the importance of persistence when seeking answers.

What tests are required to confirm Multiple myeloma?

To confirm a diagnosis of Multiple myeloma, physicians utilize a standardized battery of tests to assess both the cancerous cells and the resulting physical impact on the body:

• Serum and Urine Protein Electrophoresis: To detect the presence of "M-protein" (monoclonal protein).


• Bone Marrow Biopsy and Aspirate: To quantify the percentage of abnormal plasma cells.


• Imaging Studies: Low-dose CT, MRI, or PET/CT scans are used to identify bone lesions or plasmacytomas.


• Genetic Testing (FISH): To identify specific chromosomal abnormalities that help determine prognosis and treatment pathways for Multiple myeloma.

How is Multiple myeloma distinguished from other conditions?

Multiple myeloma must be differentiated from Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma, which are precursor conditions that do not yet meet the diagnostic threshold for active malignancy. Clinicians must also rule out metastatic bone disease and other blood cancers, such as Waldenström macroglobulinemia, which can present with similar protein-related symptoms.

Why is seeing a specialist essential for Multiple myeloma?

Because Multiple myeloma is a complex, systemic condition, it is vital to be evaluated by a hematologist-oncologist who specializes specifically in plasma cell dyscrasias. General practitioners may not see this disease frequently, and early expert intervention is crucial to managing potential complications like kidney injury or bone fractures. If you feel your symptoms are not being addressed, seeking a second opinion at a major academic cancer center can significantly reduce the time to an accurate Multiple myeloma diagnosis.

Next steps

• Consult a hematologist-oncologist with a focus on plasma cell disorders.


• Request copies of all biopsy and laboratory reports for your personal records.


• Connect with the 217 other members at DiseaseMaps.org to share experiences and support.


• Visit the Multiple Myeloma Research Foundation (MMRF) for patient-focused educational resources.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding your specific condition.

References

• National Institutes of Health (NIH) - Genetic and Rare Diseases Information Center (GARD)


• International Myeloma Working Group (IMWG) diagnostic criteria


• Multiple Myeloma Research Foundation (MMRF)


• Orphanet: Rare disease database